41 related articles for article (PubMed ID: 15539386)
1. Expression of the insulin-like growth factor (IGF) system and steroidogenic enzymes in canine testis tumors.
Peters MA; Mol JA; van Wolferen ME; Oosterlaken-Dijksterhuis MA; Teerds KJ; van Sluijs FJ
Reprod Biol Endocrinol; 2003 Feb; 1():22. PubMed ID: 12646054
[TBL] [Abstract][Full Text] [Related]
2. Renal Cell Cancer and Obesity.
Gluba-Brzózka A; Rysz J; Ławiński J; Franczyk B
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328822
[TBL] [Abstract][Full Text] [Related]
3. Menstrual cycle characteristics and incident cancer: a prospective cohort study.
Wang S; Wang YX; Sandoval-Insausti H; Farland LV; Shifren JL; Zhang D; Manson JE; Birmann BM; Willett WC; Giovannucci EL; Missmer SA; Chavarro JE
Hum Reprod; 2022 Jan; 37(2):341-351. PubMed ID: 34893843
[TBL] [Abstract][Full Text] [Related]
4. IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates.
Song W; Shao Y; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
Front Mol Biosci; 2020; 7():565173. PubMed ID: 33324675
[TBL] [Abstract][Full Text] [Related]
5. Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators.
Solarek W; Koper M; Lewicki S; Szczylik C; Czarnecka AM
J Cell Commun Signal; 2019 Sep; 13(3):381-394. PubMed ID: 30929166
[TBL] [Abstract][Full Text] [Related]
6. Context-dependent regulation of receptor tyrosine kinases: Insights from systems biology approaches.
Lam I; Pickering CM; Mac Gabhann F
Wiley Interdiscip Rev Syst Biol Med; 2019 Mar; 11(2):e1437. PubMed ID: 30255986
[TBL] [Abstract][Full Text] [Related]
7. Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma.
Wang H; Wu J; Gu W; Wang B; Wan F; Dai B; Zhang H; Shi G; Shen Y; Zhu Y; Zhu Y; Ye D
J Cancer; 2016; 7(10):1340-6. PubMed ID: 27390609
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.
Das F; Dey N; Bera A; Kasinath BS; Ghosh-Choudhury N; Choudhury GG
J Biol Chem; 2016 Jul; 291(28):14662-76. PubMed ID: 27226530
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of insulin-like growth factor 1 and its receptor in sporadic schwannoma/peripheral nerve sheath tumour.
Matsubara F; Katabami T; Asai S; Ariizumi Y; Maeda I; Takagi M; Keely MM; Ono K; Maekawa T; Nakamura Y; Tanaka Y; Sasano H
J Int Med Res; 2016 Jun; 44(3):662-72. PubMed ID: 27091859
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic effects of mammalian target of rapamycine inhibitors.
Salvadori M
World J Transplant; 2012 Oct; 2(5):74-83. PubMed ID: 24175199
[TBL] [Abstract][Full Text] [Related]
11. Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro.
Cardillo TM; Trisal P; Arrojo R; Goldenberg DM; Chang CH
BMC Cancer; 2013 Apr; 13():170. PubMed ID: 23548153
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factors and risk of kidney cancer in men.
Major JM; Pollak MN; Snyder K; Virtamo J; Albanes D
Br J Cancer; 2010 Jun; 103(1):132-5. PubMed ID: 20517306
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy.
Yuan R; Kay A; Berg WJ; Lebwohl D
J Hematol Oncol; 2009 Oct; 2():45. PubMed ID: 19860903
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer.
Huang YF; Shen MR; Hsu KF; Cheng YM; Chou CY
Br J Cancer; 2008 Oct; 99(7):1096-102. PubMed ID: 18781172
[TBL] [Abstract][Full Text] [Related]
15. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.
Hoffmann NE; Sheinin Y; Lohse CM; Parker AS; Leibovich BC; Jiang Z; Kwon ED
Cancer; 2008 Apr; 112(7):1471-9. PubMed ID: 18260086
[TBL] [Abstract][Full Text] [Related]
16. Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma.
Schips L; Zigeuner R; Ratschek M; Rehak P; Rüschoff J; Langner C
Am J Clin Pathol; 2004 Dec; 122(6):931-7. PubMed ID: 15539386
[TBL] [Abstract][Full Text] [Related]
17. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
Kornprat P; Rehak P; Rüschoff J; Langner C
J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
[TBL] [Abstract][Full Text] [Related]
18. Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines.
Rosendahl A; Forsberg G
Int J Oncol; 2004 Nov; 25(5):1327-36. PubMed ID: 15492822
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
